Bioassay SME consulting services
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00727
- Awardee
-
Bio-Val, LLC UEI F4G9WMDBVT48
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,800
Award facts
- Opportunity
-
- Bioassay Subject Matter Expert Consulting Services to Support the Development of Biologics Solicitation · 75N95022Q00498 · Posted Aug 10, 2022
- Contract value 3% obligated
-
- $14,800.00 Current, with exercised options
- $483,600.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- Cornelius, NC 28031, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $800 | |
| Exercise an Option | $4,000 | |
| Other Administrative Action | $0 | |
| Original award | $10,000 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $483,600 labor-hour contract to Bio-Val, LLC Bio-Val Consulting Division for Bioassay Subject Matter Expert Consulting Services to Support the Development of Biologics. The one-year base contract with four one-year options running through September 2025 will provide technical recommendations and advice on bioassay development and validation for modalities including monoclonal antibodies, peptide therapeutics, viral vectors, nucleic acids, cell-based therapeutics, and proteins to support programs at NIH, with an emphasis on the NIH Blueprint Neurotherapeutics Network Biologics, Ultra-Rare Gene Therapy, and Helping to End Addiction Long-term Pain Therapeutics Development initiatives. There is no set-aside designation listed.
Quick answers
Who was awarded contract 75N95022P00727?
75N95022P00727 was awarded to Bio-Val, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 21, 2022.
How much is contract 75N95022P00727 worth?
The government has obligated $14,800 on 75N95022P00727. Its potential value, with all options, is $483,600.
Which agency awarded contract 75N95022P00727?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00727, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Was contract 75N95022P00727 competed?
The extent of competition for 75N95022P00727 was competed under sap. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award